NANO-GBM trial of AGuIX nanoparticles with radiotherapy and temozolomide in the treatment of newly diagnosed Glioblastoma: Phase 1b outcomes and MRI-based biodistribution

Autor: Biau, J. a, b, c, d, ⁎, Durando, X. b, c, d, e, f, Boux, F. f, Molnar, I. a, b, c, d, Moreau, J. a, b, Leyrat, B. a, b, Guillemin, F. a, b, Lavielle, A. g, h, Cremillieux, Y. h, Seddik, K. g, Dufort, S. g, De Beaumont, O. g, Thivat, E. b, c, d, Le Duc, G. g
Zdroj: In Clinical and Translational Radiation Oncology September 2024 48
Databáze: ScienceDirect